Progress of Artificial Intelligence in Gynecological Malignant Tumors
Jie Zhou,Zhi Ying Zeng,Li Li
DOI: https://doi.org/10.2147/CMAR.S279990
2020-12-14
Cancer Management and Research
Abstract:Jie Zhou, 1, 2, * Zhi Ying Zeng, 3, * Li Li 1 1 Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning 530021, Guangxi, People's Republic of China; 2 Department of Gynecology, The Second Affiliated Hospital, University of South China, Hengyang 421001, Hunan, People's Republic of China; 3 Department of Anesthesiology, The Second Affiliated Hospital, University of South China, Hengyang 421001, Hunan, People's Republic of China *These authors contributed equally to this work Correspondence: Li Li Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Ministry of Education, Nanning 530021, Guangxi, People's Republic of China Email lili@gxmu.edu.cn Artificial intelligence (AI) is a sort of new technical science which can simulate, extend and expand human intelligence by developing theories, methods and application systems. In the last five years, the application of AI in medical research has become a hot topic in modern science and technology. Gynecological malignant tumors involves a wide range of knowledge, and AI can play an important part in these aspects, such as medical image recognition, auxiliary diagnosis, drug research and development, treatment scheme formulation and other fields. The purpose of this paper is to describe the progress of AI in gynecological malignant tumors and discuss some problems in its application. It is believed that AI improves the efficiency of diagnosis, reduces the burden of clinicians, and improves the effect of treatment and prognosis. AI will play an irreplaceable role in the field of gynecological malignant oncology and will promote the development of medicine and further promote the transformation from traditional medicine to precision medicine and preventive medicine. However, there are also some problems in the application of AI in gynecologic malignant tumors. For example, AI, inseparable from human participation, still needs to be more "humanized", and needs to further protect patients' privacy and health, improve legal and insurance protection, and further improve according to local ethnic conditions and national conditions. However, it is believed that with the continuous development of AI, especially ensemble classifier, and deep learning will have a profound influence on the future of medical technology, which is a powerful driving force for future medical innovation and reform. Keywords: artificial intelligence, gynecological malignant tumor, diagnosis, treatment, prognosis
oncology